{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:17:30Z","timestamp":1790842650528,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T00:00:00Z","timestamp":1536019200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100008363","name":"Kr\u00e6ftens Bek\u00e6mpelse","doi-asserted-by":"crossref","award":["R54-A3264"],"award-info":[{"award-number":["R54-A3264"]}],"id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Novartis Oncology"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s00277-018-3489-0","type":"journal-article","created":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T04:52:04Z","timestamp":1536036724000},"page":"101-109","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Cardiovascular disease in chronic myelomonocytic leukemia: do monocytosis and chronic inflammation predispose to accelerated atherosclerosis?"],"prefix":"10.1007","volume":"98","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2378-2511","authenticated-orcid":false,"given":"Mette Vestergaard","family":"Elb\u00e6k","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders Lindholm","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Carl","family":"Hasselbalch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,4]]},"reference":[{"key":"3489_CR1","first-page":"82","volume-title":"WHO classification of Tumours of Haematopoietic and lymphoid tissues (revised 4th edition). IARCH: Lyon","author":"A Orazi","year":"2017","unstructured":"Orazi A, Bennett JM, Germing U, Brunning RD, Bain BJ, Cazzola M, Foucar K, Thiele J (2017) Chronic myelomonocytic leukaemia. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J (eds) WHO classification of Tumours of Haematopoietic and lymphoid tissues (revised 4th edition). IARCH: Lyon, pp 82\u201386"},{"issue":"9","key":"3489_CR2","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1161\/CIRCULATIONAHA.112.000682","volume":"127","author":"A Ganda","year":"2013","unstructured":"Ganda A, Magnusson M, Yvan-Charvet L, Hedblad B, Engstrom G, Ai D, Wang TJ, Gerszten RE, Melander O, Tall AR (2013) Mild renal dysfunction and metabolites tied to low HDL cholesterol are associated with monocytosis and atherosclerosis. Circulation 127(9):988\u2013996","journal-title":"Circulation"},{"issue":"3","key":"3489_CR3","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1590\/S0066-782X2006000300013","volume":"86","author":"A Afiune Neto","year":"2006","unstructured":"Afiune Neto A, Mansur Ade P, Avakian SD, Gomes EP, Ramires JA (2006) Monocytosis is an independent risk marker for coronary artery disease. Arq Bras Cardiol 86(3):240\u2013244","journal-title":"Arq Bras Cardiol"},{"issue":"13","key":"3489_CR4","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1161\/CIRCULATIONAHA.107.745091","volume":"117","author":"C Combadiere","year":"2008","unstructured":"Combadiere C, Potteaux S, Rodero M, Simon T, Pezard A, Esposito B, Merval R, Proudfoot A, Tedgui A, Mallat Z (2008) Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6C(hi) and Ly6C(lo) monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice. Circulation 117(13):1649\u20131657","journal-title":"Circulation"},{"issue":"7","key":"3489_CR5","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1161\/01.STR.0000130857.19423.ad","volume":"35","author":"CM Chapman","year":"2004","unstructured":"Chapman CM, Beilby JP, McQuillan BM, Thompson PL, Hung J (2004) Monocyte count, but not C-reactive protein or interleukin-6, is an independent risk marker for subclinical carotid atherosclerosis. Stroke 35(7):1619\u20131624","journal-title":"Stroke"},{"issue":"9","key":"3489_CR6","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1002\/eji.201141727","volume":"41","author":"MJ Pittet","year":"2011","unstructured":"Pittet MJ, Swirski FK (2011) Monocytes link atherosclerosis and cancer. Eur J Immunol 41(9):2519\u20132522","journal-title":"Eur J Immunol"},{"issue":"14","key":"3489_CR7","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1182\/blood-2011-11-394775","volume":"119","author":"HC Hasselbalch","year":"2012","unstructured":"Hasselbalch HC (2012) Perspectives on chronic inflammation in essential thrombocythemia, polycythemia vera, and myelofibrosis: is chronic inflammation a trigger and driver of clonal evolution and development of accelerated atherosclerosis and second cancer? Blood 119(14):3219\u20133225","journal-title":"Blood"},{"issue":"12","key":"3489_CR8","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, Fonseca F, Nicolau J, Koenig W, Anker SD, Kastelein JJP, Cornel JH, Pais P, Pella D, Genest J, Cifkova R, Lorenzatti A, Forster T, Kobalava Z, Vida-Simiti L, Flather M, Shimokawa H, Ogawa H, Dellborg M, Rossi PRF, Troquay RPT, Libby P, Glynn RJ, CANTOS Trial Group (2017) Antiinflammatory therapy with Canakinumab for atherosclerotic disease. N Engl J Med 377(12):1119\u20131131","journal-title":"N Engl J Med"},{"issue":"10","key":"3489_CR9","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.autrev.2013.03.013","volume":"12","author":"I Hollan","year":"2013","unstructured":"Hollan I, Meroni PL, Ahearn JM, Cohen Tervaert JW, Curran S, Goodyear CS, Hestad KA, Kahaleh B, Riggio M, Shields K, Wasko MC (2013) Cardiovascular disease in autoimmune rheumatic diseases. Autoimmun Rev 12(10):1004\u20131015","journal-title":"Autoimmun Rev"},{"issue":"2","key":"3489_CR10","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/ncprheum0092","volume":"2","author":"Y Sherer","year":"2006","unstructured":"Sherer Y, Shoenfeld Y (2006) Mechanisms of disease: atherosclerosis in autoimmune diseases. Nat Clin Pract Rheumatol 2(2):99\u2013106","journal-title":"Nat Clin Pract Rheumatol"},{"key":"3489_CR11","doi-asserted-by":"crossref","unstructured":"Deniz Peker EP, Pedro Horna, John M. Bennett, Xiaohui Zhang, P.K. Epling-Burnette, Jeffrey E Lancet, Javier Pinilla8, Lynn Moscinski, Alan F. List, Rami S. Komrokji and Ling Zhang. A close association of history of autoimmunity with chronic myelomonocytic leukemia (CMML) in contrast to chronic myelogenous leukemia (CML). 54th ASH annual meeting and exposition; Atlanta 2012","DOI":"10.1182\/blood.V120.21.1712.1712"},{"key":"3489_CR12","doi-asserted-by":"crossref","unstructured":"Elbaek MV, Sorensen AL, Hasselbalch HC (2016) Chronic inflammation and autoimmunity as risk factors for the development of chronic myelomonocytic leukemia? Leukemia Lymphoma:1\u20137","DOI":"10.3109\/10428194.2016.1143938"},{"issue":"1","key":"3489_CR13","first-page":"13","volume":"29","author":"M Alexandrakis","year":"1998","unstructured":"Alexandrakis M, Coulocheri S, Xylouri I, Ganotakis E, Eliakis P, Karkavitsas N, Eliopoulos GD (1998) Elevated serum TNF-alpha concentrations are predictive of shortened survival in patients with high-risk myelodysplastic syndromes. Haematologia 29(1):13\u201324","journal-title":"Haematologia"},{"issue":"1","key":"3489_CR14","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1172\/JCI29950","volume":"117","author":"FK Swirski","year":"2007","unstructured":"Swirski FK, Libby P, Aikawa E, Alcaide P, Luscinskas FW, Weissleder R, Pittet MJ (2007) Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. J Clin Invest 117(1):195\u2013205","journal-title":"J Clin Invest"},{"issue":"2","key":"3489_CR15","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1161\/ATVBAHA.111.240416","volume":"32","author":"S Adamsson Eryd","year":"2012","unstructured":"Adamsson Eryd S, Smith JG, Melander O, Hedblad B, Engstrom G (2012) Incidence of coronary events and case fatality rate in relation to blood lymphocyte and neutrophil counts. Arterioscler Thromb Vasc Biol 32(2):533\u2013539","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9","key":"3489_CR16","doi-asserted-by":"publisher","first-page":"e472","DOI":"10.1038\/bcj.2016.82","volume":"6","author":"MM Patnaik","year":"2016","unstructured":"Patnaik MM, Zahid MF, Lasho TL, Finke C, Ketterling RL, Gangat N, Robertson KD, Hanson CA, Tefferi A (2016) Number and type of TET2 mutations in chronic myelomonocytic leukemia and their clinical relevance. Blood Cancer J 6(9):e472","journal-title":"Blood Cancer J"},{"issue":"2","key":"3489_CR17","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1701719","volume":"377","author":"S Jaiswal","year":"2017","unstructured":"Jaiswal S, Natarajan P, Silver AJ, Gibson CJ, Bick AG, Shvartz E, McConkey M, Gupta N, Gabriel S, Ardissino D, Baber U, Mehran R, Fuster V, Danesh J, Frossard P, Saleheen D, Melander O, Sukhova GK, Neuberg D, Libby P, Kathiresan S, Ebert BL (2017) Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease. N Engl J Med 377(2):111\u2013121","journal-title":"N Engl J Med"},{"issue":"11","key":"3489_CR18","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1038\/leu.2013.102","volume":"27","author":"C Marty","year":"2013","unstructured":"Marty C, Lacout C, Droin N, Le Couedic JP, Ribrag V, Solary E et al (2013) A role for reactive oxygen species in JAK2 V617F myeloproliferative neoplasm progression. Leukemia 27(11):2187\u20132195","journal-title":"Leukemia"},{"issue":"3","key":"3489_CR19","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s12185-014-1670-3","volume":"101","author":"K Zoi","year":"2015","unstructured":"Zoi K, Cross NC (2015) Molecular pathogenesis of atypical CML, CMML and MDS\/MPN-unclassifiable. Int J Hematol 101(3):229\u2013242","journal-title":"Int J Hematol"},{"issue":"1","key":"3489_CR20","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/bjh.12099","volume":"160","author":"C Nielsen","year":"2013","unstructured":"Nielsen C, Birgens HS, Nordestgaard BG, Bojesen SE (2013) Diagnostic value of JAK2 V617F somatic mutation for myeloproliferative cancer in 49 488 individuals from the general population. Br J Haematol 160(1):70\u201379","journal-title":"Br J Haematol"},{"key":"3489_CR21","unstructured":"Molenaar RJ, Radivoyevitch T, Sekeres MA, Mukherjee S, Maciejewski JP (2017) High rates of atherosclerotic disease-related mortality in myelodysplastic syndromes and chronic myelomonocytic leukemia patients associated with TET2-mutations. ASH 59th annual meeting & exposition; December 10th Atlanta, GA. Blood:421"},{"issue":"5","key":"3489_CR22","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","volume":"114","author":"JW Vardiman","year":"2009","unstructured":"Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A, Harris NL, le Beau MM, Hellstrom-Lindberg E, Tefferi A, Bloomfield CD (2009) The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 114(5):937\u2013951","journal-title":"Blood"},{"key":"3489_CR23","doi-asserted-by":"crossref","unstructured":"Lindholm Sorensen A, Hasselbalch HC (2015) Smoking and Philadelphia-negative chronic myeloproliferative neoplasms. Eur J Haematol","DOI":"10.1111\/ejh.12684"},{"issue":"23","key":"3489_CR24","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1182\/blood-2015-01-620781","volume":"125","author":"D Selimoglu-Buet","year":"2015","unstructured":"Selimoglu-Buet D, Wagner-Ballon O, Saada V, Bardet V, Itzykson R, Bencheikh L, Morabito M, Met E, Debord C, Benayoun E, Nloga AM, Fenaux P, Braun T, Willekens C, Quesnel B, Ades L, Fontenay M, Rameau P, Droin N, Koscielny S, Solary E, on behalf of the Groupe Francophone des Myelodysplasies (2015) Characteristic repartition of monocyte subsets as a diagnostic signature of chronic myelomonocytic leukemia. Blood 125(23):3618\u20133626","journal-title":"Blood"},{"issue":"1","key":"3489_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2050-7771-2-1","volume":"2","author":"J Yang","year":"2014","unstructured":"Yang J, Zhang L, Yu C, Yang XF, Wang H (2014) Monocyte and macrophage differentiation circulation inflammatory monocyte as biomarker for inflammatory diseases. Biomarker Res 2(1):1","journal-title":"Biomarker Res"},{"issue":"3","key":"3489_CR26","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/sji.12314","volume":"82","author":"E Idzkowska","year":"2015","unstructured":"Idzkowska E, Eljaszewicz A, Miklasz P, Musial WJ, Tycinska AM, Moniuszko M (2015) The role of different monocyte subsets in the pathogenesis of atherosclerosis and acute coronary syndromes. Scand J Immunol 82(3):163\u2013173","journal-title":"Scand J Immunol"},{"key":"3489_CR27","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1038\/leu.2017.164","volume":"31","author":"BJ Patel","year":"2017","unstructured":"Patel BJ, Przychodzen B, Thota S, Radivoyevitch T, Visconte V, Kuzmanovic T, Clemente M, Hirsch C, Morawski A, Souaid R, Saygin C, Nazha A, Demarest B, LaFramboise T, Sakaguchi H, Kojima S, Carraway HE, Ogawa S, Makishima H, Sekeres MA, Maciejewski JP (2017) Genomic determinants of chronic myelomonocytic leukemia. Leukemia 31:2815\u20132823","journal-title":"Leukemia"},{"key":"3489_CR28","unstructured":"Hanna BS, Ozturk S, Seiffert M (2017) Beyond bystanders: myeloid cells in chronic lymphocytic leukemia. Mol Immunol"},{"issue":"7","key":"3489_CR29","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/nrc.2017.40","volume":"17","author":"MWN Deininger","year":"2017","unstructured":"Deininger MWN, Tyner JW, Solary E (2017) Turning the tide in myelodysplastic\/myeloproliferative neoplasms. Nat Rev Cancer 17(7):425\u2013440","journal-title":"Nat Rev Cancer"},{"issue":"7569","key":"3489_CR30","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/nature15252","volume":"525","author":"Q Zhang","year":"2015","unstructured":"Zhang Q, Zhao K, Shen Q, Han Y, Gu Y, Li X, Zhao D, Liu Y, Wang C, Zhang X, Su X, Liu J, Ge W, Levine RL, Li N, Cao X (2015) Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6. Nature 525(7569):389\u2013393","journal-title":"Nature"},{"issue":"2","key":"3489_CR31","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1182\/blood-2014-04-555508","volume":"125","author":"T Kameda","year":"2015","unstructured":"Kameda T, Shide K, Yamaji T, Kamiunten A, Sekine M, Taniguchi Y, Hidaka T, Kubuki Y, Shimoda H, Marutsuka K, Sashida G, Aoyama K, Yoshimitsu M, Harada T, Abe H, Miike T, Iwakiri H, Tahara Y, Sueta M, Yamamoto S, Hasuike S, Nagata K, Iwama A, Kitanaka A, Shimoda K (2015) Loss of TET2 has dual roles in murine myeloproliferative neoplasms: disease sustainer and disease accelerator. Blood 125(2):304\u2013315","journal-title":"Blood"},{"issue":"1","key":"3489_CR32","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/ajh.24607","volume":"92","author":"A Tefferi","year":"2017","unstructured":"Tefferi A, Barbui T (2017) Polycythemia vera and essential thrombocythemia: 2017 update on diagnosis, risk-stratification, and management. Am J Hematol 92(1):94\u2013108","journal-title":"Am J Hematol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-018-3489-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3489-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3489-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T02:05:54Z","timestamp":1589940354000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-018-3489-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,4]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["3489"],"URL":"https:\/\/doi.org\/10.1007\/s00277-018-3489-0","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,4]]},"assertion":[{"value":"30 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was reported to The Danish Data Protection Agency, approved by The Danish Health and Medicines Authority, and it was conducted in accordance with the ethical principles stated in the Declaration of Helsinki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"ALS has received a grant from the Danish Cancer Society under Grant no. R54-A3264. HCS has received research funding from Novartis Oncology. MVE has no conflict of interest to declare.The sources of funding had no involvement in the study design, collection, analysis, or interpretation of data; writing of the report; or the decision to submit the work for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"For this retrospective study, formal consent is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}